News Conference News TCT 2019 Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE Michael O'Riordan September 30, 2019
News Conference News TCT 2019 TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 Yael L. Maxwell September 29, 2019
News Conference News TCT 2019 Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk Michael O'Riordan September 29, 2019
News Conference News TCT 2019 New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing Todd Neale September 28, 2019
News Conference News TCT 2019 Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis Michael O'Riordan September 27, 2019
News Conference News TCT 2019 Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients Yael L. Maxwell September 27, 2019
News Conference News TCT 2019 Learning Curve Exists for MitraClip, Volume-Outcomes Data Hint Todd Neale September 27, 2019
News Conference News TCT 2019 AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups Todd Neale September 26, 2019
News Conference News TCT 2019 Strokes Increasing in STEMI Patients With Cardiogenic Shock Todd Neale September 25, 2019
News Conference News TCT 2019 Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease Michael O'Riordan September 25, 2019
News Conference News TCT 2019 From Ceiling Suspension to Eye-Tracking: Innovation Continues for Cath Lab Radiation Protection Yael L. Maxwell September 25, 2019
News Conference News HFSA 2019 Old Dog, New Tricks? HOMAGE Hints at Role for Spironolactone in HF Prevention L.A. McKeown September 24, 2019
News Conference News HFSA 2019 Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF L.A. McKeown September 23, 2019
News Conference News TCT 2019 TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More Shelley Wood September 19, 2019
News Conference News HFSA 2019 New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF L.A. McKeown September 18, 2019
News Conference News HFSA 2019 DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF L.A. McKeown September 16, 2019
News Conference News ESC 2019 Primary Prevention ICDs Still Render Better Survival, Even in Modern HFrEF Patients Todd Neale September 13, 2019
News Conference News ESC 2019 GARFIELD-AF Analysis Digs Into Impact of Bleeding in Newly Diagnosed A-fib Todd Neale September 12, 2019
News Conference News ESC 2019 Beta-blockers Safe, Effective for HFrEF Patients With Renal Dysfunction: Meta-analysis Yael L. Maxwell September 12, 2019
News Conference News ESC 2019 Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints Todd Neale September 11, 2019